Alterity Therapeutics Limited (PRNAF)
OTCMKTS
· Delayed Price · Currency is USD
0.0036
-0.0032 (-47.06%)
At close: Jul 25, 2024
Alterity Therapeutics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Other Revenue | 4.02 | 4.02 | 3.92 | 5.12 | 4.34 | - | Upgrade
|
| Revenue | 4.02 | 4.02 | 3.92 | 5.12 | 4.34 | - | Upgrade
|
| Revenue Growth (YoY) | 2.63% | 2.63% | -23.56% | 18.06% | - | - | Upgrade
|
| Cost of Revenue | 0.21 | 0.21 | 0.29 | 0.36 | 0.36 | 0.35 | Upgrade
|
| Gross Profit | 3.8 | 3.8 | 3.63 | 4.76 | 3.98 | -0.35 | Upgrade
|
| Selling, General & Admin | 4.76 | 4.76 | 5.06 | 5.51 | 6.94 | 3.45 | Upgrade
|
| Research & Development | 18.64 | 18.64 | 13.2 | 14.75 | 12.28 | 10.1 | Upgrade
|
| Other Operating Expenses | 0.01 | 0.01 | 0.03 | 0 | 0 | 0.04 | Upgrade
|
| Operating Expenses | 23.41 | 23.41 | 18.27 | 20.26 | 19.16 | 13.58 | Upgrade
|
| Operating Income | -19.61 | -19.61 | -14.64 | -15.5 | -15.18 | -13.93 | Upgrade
|
| Interest & Investment Income | 0.27 | 0.27 | 0.02 | 0 | 0.02 | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.26 | 0.26 | 0.92 | 2.72 | -0.3 | 0.33 | Upgrade
|
| EBT Excluding Unusual Items | -19.08 | -19.08 | -13.7 | -12.78 | -15.45 | -13.58 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.15 | 0.12 | Upgrade
|
| Pretax Income | -19.08 | -19.08 | -13.7 | -12.78 | -15.31 | -13.46 | Upgrade
|
| Income Tax Expense | 0.05 | 0.05 | 0.1 | 0.07 | - | - | Upgrade
|
| Net Income | -19.12 | -19.12 | -13.81 | -12.85 | -15.31 | -13.46 | Upgrade
|
| Net Income to Common | -19.12 | -19.12 | -13.81 | -12.85 | -15.31 | -13.46 | Upgrade
|
| Shares Outstanding (Basic) | 3,649 | 3,649 | 2,428 | 2,406 | 1,697 | 895 | Upgrade
|
| Shares Outstanding (Diluted) | 3,649 | 3,649 | 2,428 | 2,406 | 1,697 | 895 | Upgrade
|
| Shares Change (YoY) | 50.29% | 50.29% | 0.91% | 41.79% | 89.62% | 45.33% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | Upgrade
|
| Free Cash Flow | -12.61 | -12.61 | -20.04 | -12.43 | -17.34 | -9.45 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Gross Margin | 94.67% | 94.67% | 92.72% | 92.88% | 91.70% | - | Upgrade
|
| Operating Margin | -487.82% | -487.82% | -373.72% | -302.56% | -349.77% | - | Upgrade
|
| Profit Margin | -475.79% | -475.79% | -352.54% | -250.75% | -352.78% | - | Upgrade
|
| Free Cash Flow Margin | -313.78% | -313.78% | -511.78% | -242.54% | -399.59% | - | Upgrade
|
| EBITDA | -19.57 | -19.57 | -14.6 | -15.48 | -15.16 | -13.9 | Upgrade
|
| D&A For EBITDA | 0.04 | 0.04 | 0.04 | 0.02 | 0.02 | 0.03 | Upgrade
|
| EBIT | -19.61 | -19.61 | -14.64 | -15.5 | -15.18 | -13.93 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.